Central line nursing: PICC, CVC, and vascular access care guide

Central venous access devices – PICC lines, central venous catheters, tunneled catheters, and implanted ports – are among the most common and highest-risk devices nurses manage in acute care, oncology, and long-term care settings. Unlike a peripheral IV, a central line terminates in or near the superior vena cava, allowing infusion of vesicants, hyperosmolar solutions, and medications that would destroy peripheral veins. That access comes with serious responsibilities: infection prevention, accurate tip verification, safe flushing, and rapid recognition of life-threatening complications.

NCLEX tests central line nursing extensively because the consequences of errors – central line–associated bloodstream infections (CLABSIs), air embolism, venous thrombosis – are largely preventable and can be fatal. This guide covers every high-yield topic from device types to removal, with a focused NCLEX tips section at the end.

Types of central venous access devices

Not every “central line” is the same. The table below compares the major device categories a nurse will encounter.

The midline vs. central line distinction

A midline catheter is frequently confused with a PICC on NCLEX. The critical difference is tip location. A midline catheter tip sits in the axillary or subclavian vein – it never reaches the superior vena cava. That makes it a long peripheral, not a central line. Vesicants, parenteral nutrition with high dextrose concentration, and continuous vasoactive infusions require a true central line (SVC or beyond).

Tip placement verification

A newly inserted central venous catheter must not be used until tip placement is confirmed. The classic method, and the expected NCLEX answer, is a chest X-ray; some facilities also approve other tip-confirmation methods (such as ECG-guided tip location during PICC insertion), so follow local policy on which method counts. This is one of the highest-yield NCLEX discriminators related to central lines.

The correct tip position for any non-femoral central line is the lower third of the SVC or the SVC–right atrial junction. A tip positioned too high (in the subclavian or innominate vein) creates infusion risk – vesicants or hyperosmolar solutions delivered into smaller vessels can cause sclerosis or perforation. A tip advanced too far into the right atrium or ventricle risks arrhythmias and, rarely, perforation.

For femoral central lines, the expected tip location is the inferior vena cava or iliac vein. Femoral lines are confirmed by abdominal/pelvic X-ray.

Complications of insertion to monitor

In the first hour after central line insertion, the nurse must assess for:

• Pneumothorax – subclavian and internal jugular insertions carry this risk; watch for sudden dyspnea, absent breath sounds, tracheal deviation (tension pneumothorax). Confirmed on CXR.
• Hemothorax – blood into pleural space from vessel injury; decreased breath sounds, dullness to percussion, hemodynamic instability.
• Arterial puncture – bright red blood under pressure during cannulation; apply direct pressure and notify the provider immediately; do not advance the catheter.
• Air embolism – covered in detail below.

Monitor vital signs, oxygen saturation, and respiratory status closely after insertion, per facility policy. A small pneumothorax can enlarge over the following hours, so new dyspnea or chest pain later in the shift still needs reporting.

CLABSI prevention bundle

Central line–associated bloodstream infections (CLABSIs) are among the most serious preventable complications of central venous access. (CLABSI is the surveillance term used for infection reporting; catheter-related bloodstream infection, CRBSI, is the stricter clinical diagnosis that links the bloodstream organism to the catheter itself.) The five-element bundle below comes from the Michigan Keystone ICU project: across 103 ICUs, the median CLABSI rate fell from 2.7 per 1,000 catheter-days to 0 within 3 months, and the mean rate fell from 7.7 to 1.4 by 16–18 months (Pronovost 2006). CDC 2011 and SHEA 2022 recommendations support each element. Each one is individually testable on NCLEX.

The five core bundle elements

1. Hand hygiene. Wash hands or use alcohol-based hand rub before and after any contact with the catheter, connections, or dressing. This applies to every nurse, every time – there are no exceptions based on glove use.

2. Maximum sterile barrier precautions during insertion. The inserting provider wears a sterile gown, sterile gloves, mask, and cap. The patient is covered with a large sterile full-body drape (CDC 2011, Category IB). Most facility policies also ask anyone assisting at the bedside to wear a cap and mask. Maximum barrier precautions go further than the sterile gloves and small drape used for routine sterile technique.

3. Chlorhexidine skin antisepsis. CDC 2011 calls for a chlorhexidine preparation stronger than 0.5% in alcohol, and SHEA 2022 specifies at least 2% chlorhexidine gluconate in alcohol; the usual product is 2% CHG in 70% isopropyl alcohol (CHG/IPA). Scrub and dry times come from the product label. For ChloraPrep, a dry site such as the abdomen or arm gets 30 seconds of back-and-forth friction and about 30 seconds of air drying, while a moist site such as the inguinal fold gets 2 minutes of friction and about 1 minute of drying. Do not blot or wipe the antiseptic away, and do not puncture the skin until it is dry. If chlorhexidine is contraindicated, CDC lists tincture of iodine, an iodophor (povidone-iodine), or 70% alcohol as alternatives.

4. Optimal catheter site selection. For non-tunneled CVCs in adult ICU patients, the subclavian vein is the preferred site (SHEA 2022). In the 3SITES randomized trial of 3,471 catheters, the combined rate of catheter-related bloodstream infection and symptomatic DVT was 1.5 per 1,000 catheter-days for subclavian, 3.6 for jugular, and 4.6 for femoral; subclavian also caused the most pneumothoraces needing a chest tube (1.5% vs 0.5% for jugular) (Parienti 2015). CDC 2011 still advises avoiding the femoral vein in adults, but the infection gap is smaller than older teaching suggests: a meta-analysis found no significant difference in bloodstream infection between femoral and the other two sites in recent studies (Marik 2012). Site choice balances infection, thrombosis, and procedural risk for the individual patient, and in an emergency the fastest reliable access wins.

5. Daily necessity review – remove when no longer needed. Prolonged duration of catheterization is an independent risk factor for CLABSI, and SHEA 2022 calls for a daily review of whether the line is still needed. Every shift, the nurse should confirm the line is still clinically required. Document your assessment. If you question whether the line is still needed, bring it to the provider – removal of an unnecessary line is a nursing intervention.

Dressing changes

When performing the dressing change, inspect the insertion site for erythema, swelling, induration, exudate, and tenderness. Measure and document the external catheter length – a change from baseline indicates catheter migration (inward or outward). Use CHG antisepsis on the site during each change. The full step-by-step procedure is in the central line dressing change guide.

Scrub the hub

Before every access to the catheter – before drawing blood, administering medications, or attaching tubing – scrub the needleless connector (hub) with 70% isopropyl alcohol or an alcohol-based chlorhexidine product, then allow it to dry fully. This mechanical friction removes biofilm and surface contaminants.

SHEA 2022 rates hub, connector, and port disinfection before every access as an essential practice: apply mechanical friction with alcoholic chlorhexidine (preferred, for its residual activity) or 70% alcohol for a minimum of 5 seconds, while noting that the studies behind that figure may not apply to every needleless connector design. The INS 2024 Standards of Practice likewise defer to the connector and disinfectant manufacturers’ instructions for scrub and dry times. Passive disinfection caps containing alcohol are an accepted alternative. Nursing programs and NCLEX review materials generally teach 15 seconds as the working minimum, and that is the figure to select on an exam; it sits comfortably above the evidence-based floor. Drying time matters as much as scrub time: an incompletely dried hub has not been disinfected.

Flushing protocols

Proper flushing maintains catheter patency, prevents medication incompatibilities, and reduces thrombotic occlusion.

SASH protocol

The mnemonic for flushing a heparin-locked central line is:

• S – Saline (NS flush before)
• A – Administer medication
• S – Saline (NS flush after)
• H – Heparin (lock)

For lines locked with saline only (many facilities now use NS locks for some devices), the sequence is SAS (saline–administer–saline). Confirm facility policy.

Flush volumes and technique

• Routine saline flush volume: 10 mL normal saline before and after each medication (Goossens 2015). Flush with saline before and after blood sampling too (the SBS sequence).
• After blood sampling: at least 10 mL NS. After blood products, parenteral nutrition, or contrast: 20 mL NS, because these viscous products cling to the lumen wall (Goossens 2015). Many facility policies also use 20 mL after blood draws; follow yours.
• Lock volume and solution: the lock only needs to fill the catheter’s internal volume plus about 15–20% for leakage. Goossens 2015 recommends 1.5 mL for midlines, PICCs, and nontunneled CVC lumens and 2.5 mL for large-bore tunneled catheters and ports, although many policies use 3–5 mL. Heparin locks are commonly 10 or 100 units/mL, and saline-only locks are increasingly used. Concentration and volume are set by facility policy and the catheter manufacturer, and pediatric and neonatal protocols differ significantly.
• Flushing technique: use a push-pause (pulsatile) technique – inject in small boluses (about 1 mL) with brief pauses. In laboratory studies, this unsteady flow removes deposits from the lumen wall more effectively than a smooth continuous push.
• Disconnection technique depends on the connector. The manual positive-pressure technique (keep pushing the plunger while withdrawing the syringe, or clamp while injecting the last 0.5 mL) was designed for standard caps and negative-displacement connectors. Positive-displacement and neutral connectors are engineered to do this job themselves, so follow the connector manufacturer’s clamp-and-disconnect sequence instead (Goossens 2015).

Lumens that are not in use still need regular flushing and locking at the interval facility policy sets. Goossens 2015 summarizes common regimens as every 8–24 hours for short-term catheters, weekly for long-term catheters, and every 6–8 weeks for ports.

Complications and management

The table below summarizes the two highest-yield catheter complications on NCLEX. Air embolism and catheter occlusion are managed differently; confusing them can be fatal.

Air embolism prevention

Prevention is more effective than treatment. The following measures reduce air entry risk during line management:

• Trendelenburg positioning during insertion – increases central venous pressure, reducing the pressure gradient that draws air into the vein during needle puncture.
• Valsalva maneuver during tubing disconnection – patient bears down or holds their breath, briefly raising intrathoracic pressure and CVP; performed at the moment a cap or tubing is removed.
• Luer-lock connections exclusively – all IV tubing, caps, and extension sets connected to central lines must use luer-lock fittings, not slip-tip. A slip-tip connection can pull apart during a position change or patient movement and open the line to air.
• Tubing changes with the patient supine – never perform tubing or cap changes with the patient sitting upright; this position creates the greatest negative pressure gradient.

Catheter occlusion: mechanical vs. thrombotic vs. precipitate

Nurses must distinguish occlusion types before calling the provider:

• Mechanical occlusion – the catheter is kinked, a clamp is inadvertently closed, or a PICC is positionally occluded by arm position. Reposition the arm, check all external components, and reassess. If it clears, document and monitor.
• Thrombotic occlusion – the lumen is blocked by a blood clot or fibrin sheath. Characterized by inability to flush or aspirate. Treat with tPA as described above.
• Precipitate occlusion – two incompatible medications were infused sequentially without adequate flushing, forming a chemical precipitate in the lumen. Example: calcium and phosphate, phenytoin in dextrose. A precipitate occlusion will NOT respond to tPA. Management involves identifying the incompatible agents and sometimes instilling a solvent matched to the deposit: 70% ethanol for lipid residue from parenteral nutrition, dilute hydrochloric acid for calcium phosphate crystals and low-pH drug precipitates, and sodium bicarbonate or sodium hydroxide for high-pH drug precipitates (Baskin 2012). This is always a pharmacy and provider decision.

Central line removal

Removal of a central line carries its own risk of air embolism. The nurse’s role in removal requires the same attention to positioning and pressure changes as insertion.

Before removal:

• Confirm the order; explain the procedure to the patient.
• Gather supplies: sterile gloves, sterile gauze, chlorhexidine swabs, sterile occlusive dressing.
• Position the patient supine or in slight Trendelenburg – never in an upright or semi-Fowler’s position. Sitting up during removal creates negative intrathoracic pressure that draws air in through the catheter tract immediately after the catheter exits.

During removal:

• Have the patient perform the Valsalva maneuver (bear down or hum) at the moment the catheter clears the vessel. This raises intrathoracic pressure and counteracts air entry.
• Withdraw the catheter smoothly and continuously in one motion.
• Apply firm pressure to the insertion site immediately – hold for a minimum of 1–2 minutes (longer for patients on anticoagulants, or until hemostasis is confirmed).

After removal:

• Apply a sterile occlusive dressing to the site. Leave it in place for at least 24 hours – this is the window of highest risk for air entry through the residual catheter tract.
• Inspect the catheter tip: it must be intact. Measure the removed catheter length and compare it to the documented insertion length. A discrepancy indicates catheter fracture and retained fragment – a medical emergency requiring imaging.
• Document: time of removal, catheter tip integrity, dressing applied, patient tolerance, neurovascular status of the insertion site.

NCLEX tips

These are the discriminators that separate correct from incorrect answers on NCLEX central line questions.

• Never infuse through a new central line until tip placement is confirmed. This is the most commonly tested central line rule. On NCLEX the order of operations is: insert → chest X-ray → confirm tip in lower SVC → then use.
• Femoral is the site NCLEX expects you to question; subclavian is the preferred site for nontunneled adult ICU lines. CDC 2011 advises avoiding the femoral vein in adults, and in the 3SITES trial femoral and jugular lines both had more infections plus DVTs than subclavian lines. Newer data show the femoral infection risk is close to that of the jugular site (Marik 2012; Vaughan-Masamitsu 2025), so in practice the choice is individualized, and femoral access is often the fastest option in an emergency.
• Durant’s maneuver = left lateral decubitus + Trendelenburg. This position traps air in the right ventricular apex, away from the pulmonary outflow tract, buying time for absorption and hemodynamic stabilization.
• Luer-lock connections prevent air embolism. Slip-tip connections have no place on a central line. Any NCLEX question asking what prevents air embolism during tubing changes – luer-lock connections are part of the answer.
• Scrub the hub for at least 15 seconds before every access, and let it dry. On NCLEX, 15 seconds is the expected answer and shorter times are distractors. In practice, INS 2024 defers to the connector manufacturer’s instructions rather than fixing a single number.
• Match the disconnection technique to the connector. Manual positive pressure (keep pushing while withdrawing the syringe) prevents blood reflux with standard and negative-displacement connectors; positive- and neutral-displacement connectors have their own manufacturer-specified clamp and disconnect sequence.
• Non-coring Huber needle for implanted ports – a regular needle cores the silicone port septum and destroys it permanently. On NCLEX, if the question describes accessing a port and lists needle types, Huber (non-coring) is always correct.
• Assess mid-upper arm circumference for PICC patients. Compare every measurement with the baseline taken at insertion and report any increase, particularly with arm swelling or pain. No single cutoff is validated; in one prospective cohort, a rise of 3 cm or more with edema was associated with DVT (Maneval 2014).
• Do NOT take blood pressure, perform venipuncture, or start a peripheral IV in the PICC arm. These activities can damage the catheter and the vessel. Use the contralateral arm for blood pressure measurements.
• CLABSI assessment is daily, not once. Every shift, the nurse assesses for fever, chills, and site findings; every shift, the nurse confirms the line is still necessary. Documenting daily necessity review is part of the bundle.
• Do NOT replace a suspected-infected non-tunneled catheter over a guidewire (CDC 2011). Guidewire exchange keeps the original tract and does not eliminate the source of infection. When the provider removes the line, the tip may be sent for culture, and a new line goes in at a different site if access is still needed.
• Alteplase (Cathflo Activase) treats thrombotic occlusion. The adult dose (30 kg or more) is 2 mg in 2 mL, with function checked at 30 and 120 minutes; a second dose may be given if the catheter still does not work at 120 minutes. Alteplase does not treat precipitate or mechanical occlusion.
• Transparent dressing changes at least every 7 days; gauze dressing changes every 2 days. Change either immediately if damp, soiled, or loose.
• Valsalva maneuver on removal raises intrathoracic pressure at the moment the catheter exits the vessel – this is the mechanism by which it prevents air embolism during removal.

Related skills

Central line nursing sits at the intersection of several high-acuity nursing competencies. Deepen your understanding with these related topics:

• IV insertion nursing – peripheral access technique, vein selection, and infiltration management
• Infective endocarditis nursing – how bacteremia from catheter infections can seed cardiac valves
• Septic shock nursing – a CLABSI can progress to sepsis and septic shock, and management overlaps significantly
• Chest tube nursing – pneumothorax and hemothorax are both post-insertion complications of subclavian and IJ catheterization
• Blood transfusion nursing – rapid infusion products and massive transfusion protocols frequently require central venous access

References

1. O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clinical Infectious Diseases. 2011;52(9):e162–e193. doi:10.1093/cid/cir257
2. Centers for Disease Control and Prevention. Guidelines for the Prevention of Intravascular Catheter-Related Infections (2011; chlorhexidine-dressing recommendations updated July 2017; last update October 2017). Atlanta, GA: CDC. https://www.cdc.gov/infection-control/media/pdfs/Guideline-BSI-H.pdf
3. Nickel B, Gorski L, Kleidon T, et al. Infusion therapy standards of practice, 9th edition. Journal of Infusion Nursing. 2024;47(1S):S1–S285. doi:10.1097/NAN.0000000000000532 (INS moved from a 5-year to a 3-year revision cycle at this edition; the 8th edition, 2021;44(1S):S1–S224, is superseded.)
4. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2009;49(1):1–45. doi:10.1086/599376
5. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. New England Journal of Medicine. 2006;355(26):2725–2732. doi:10.1056/NEJMoa061115
6. Puig-Asensio M, Marra AR, Childs CA, Kukla ME, Perencevich EN, Schweizer ML. Effectiveness of chlorhexidine dressings to prevent catheter-related bloodstream infections. Does one size fit all? A systematic literature review and meta-analysis. Infection Control and Hospital Epidemiology. 2020;41(12):1388–1395. doi:10.1017/ice.2020.356
7. Chopra V, Flanders SA, Saint S, et al. The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): results from a multispecialty panel using the RAND/UCLA appropriateness method. Annals of Internal Medicine. 2015;163(6 Suppl):S1–S40. doi:10.7326/M15-0744
8. Goss L, ed. Guide to Preventing Central Line–Associated Bloodstream Infections. APIC Implementation Guide. Washington, DC: Association for Professionals in Infection Control and Epidemiology; 2015.
9. Crawford JD, Liem TK, Moneta GL. Management of catheter-associated upper extremity deep venous thrombosis. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2016;4(3):375–379. doi:10.1016/j.jvsv.2015.06.003
10. Pittiruti M, Hamilton H, Biffi R, MacFie J, Pertkiewicz M. ESPEN guidelines on parenteral nutrition: central venous catheters (access, care, diagnosis and therapy of complications). Clinical Nutrition. 2009;28(4):365–377. doi:10.1016/j.clnu.2009.03.015
11. Ignatavicius DD, Rebar CR, Heimgartner NM. Medical-Surgical Nursing: Concepts for Clinical Judgment and Collaborative Care. 11th ed. St. Louis, MO: Elsevier; 2023. (The title and author line both changed at the 11th edition; earlier printings appear as Concepts for Interprofessional Collaborative Care.)
12. Urden LD, Stacy KM, Lough ME, Sanchez K. Critical Care Nursing: Diagnosis and Management. 10th ed. St. Louis, MO: Elsevier; 2025.
13. Potter PA, Perry AG, Stockert PA, Hall AM, Ostendorf WR. Fundamentals of Nursing. 12th ed. St. Louis, MO: Elsevier; 2026.
14. NANDA International. Nursing Diagnoses: Definitions and Classification 2024–2026. 13th ed. New York, NY: Thieme; 2024.
15. Buetti N, Marschall J, Drees M, et al. Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 update. Infection Control and Hospital Epidemiology. 2022;43(5):553–569. doi:10.1017/ice.2022.87
16. Parienti JJ, Mongardon N, Mégarbane B, et al. Intravascular complications of central venous catheterization by insertion site. New England Journal of Medicine. 2015;373(13):1220–1229. doi:10.1056/NEJMoa1500964
17. Marik PE, Flemmer M, Harrison W. The risk of catheter-related bloodstream infection with femoral venous catheters as compared to subclavian and internal jugular venous catheters: a systematic review of the literature and meta-analysis. Critical Care Medicine. 2012;40(8):2479–2485. doi:10.1097/CCM.0b013e318255d9bc
18. Vaughan-Masamitsu A, Paulson W, Hodes R, Dudek C. Reassessing the risk: a retrospective analysis of CLABSI risk in femoral, internal jugular, and subclavian central venous catheters. Critical Care Research and Practice. 2025;2025:8193419. doi:10.1155/ccrp/8193419 (TriNetX cohort, 65,265 propensity-matched patients: femoral not significantly higher than other sites; jugular significantly higher than subclavian.)
19. Goossens GA. Flushing and locking of venous catheters: available evidence and evidence deficit. Nursing Research and Practice. 2015;2015:985686. doi:10.1155/2015/985686
20. Maneval RE, Clemence BJ. Risk factors associated with catheter-related upper extremity deep vein thrombosis in patients with peripherally inserted central venous catheters: a prospective observational cohort study: part 2. Journal of Infusion Nursing. 2014;37(4):260–268. doi:10.1097/NAN.0000000000000042
21. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e419S–e496S. doi:10.1378/chest.11-2301
22. Baskin JL, Reiss U, Wilimas JA, et al. Thrombolytic therapy for central venous catheter occlusion. Haematologica. 2012;97(5):641–650. doi:10.3324/haematol.2011.050492
23. Genentech, Inc. Cathflo Activase (alteplase) injection, powder, lyophilized, for solution [prescribing information]. DailyMed setid 91ecdef2-95ff-42dd-a31c-c8a09cab3ad9; label text revised 02/2019, DailyMed SPL version January 2026. Accessed October 18, 2026.
24. CareFusion 213, LLC. ChloraPrep One-Step (2% chlorhexidine gluconate and 70% isopropyl alcohol) [drug facts label]. DailyMed setid 8528a4f5-5ff4-45f3-e053-2991aa0a804c; November 2025. Accessed October 18, 2026.